Advertisement
U.S. Markets closed

Clarity Pharmaceuticals Ltd (CLRPF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
4.55200.0000 (0.00%)
At close: 04:00PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/30/2024
6/30/2023
6/30/2022
Operating Expense
30,291
56,307
36,164
30,291
Operating Income
-30,291
-56,307
-36,164
-30,291
Net Non Operating Interest Income Expense
95.093
2,771
1,864
95.093
Other Income Expense
6,459
11,507
9,801
6,459
Pretax Income
-23,737
-42,029
-24,499
-23,737
Tax Provision
17.632
295.151
103.2
17.632
Net Income Common Stockholders
-23,755
-42,324
-24,602
-23,755
Basic EPS
-0.10
-
-0.09
-0.10
Diluted EPS
-0.10
-
-0.09
-0.10
Basic Average Shares
259,604
-
260,410
248,465
Diluted Average Shares
259,604
-
260,410
248,465
Net Income from Continuing & Discontinued Operation
-23,755
-42,324
-24,602
-23,755
Normalized Income
-23,755
-42,324
-24,602
-23,755
Interest Income
95.093
2,771
1,864
95.093
Net Interest Income
95.093
2,771
1,864
95.093
EBIT
-30,291
-56,307
-36,164
-30,291
EBITDA
-30,245
-56,154
-36,064
-30,245
Reconciled Depreciation
46.249
153.068
100.513
46.249
Net Income from Continuing Operation Net Minority Interest
-23,755
-42,324
-24,602
-23,755
Normalized EBITDA
-30,245
-56,154
-36,064
-30,245
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0